More cancer than cardiac deaths in patients with mild renal disease
Clinical trial to launch in 2016
“I saw this ad on TV and I would try this immune-therapy stuff”
Patterns of DNA Methylation May Differentiate Indolent and Aggressive Prostate Cancers
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Molecular data enhance traditional scoring systems
Research improving myelodysplastic syndromes treatment
Complex karyotypes, TET2 mutations lower survival rates
Cleveland Clinic researchers warn against overtreatment
Insurance data analysis uncovers real-world behaviors
Response in patient subgroups shows promise, however
Advertisement
Advertisement